Table 11.

Comparison in terms of average balanced accuracy and number of selected features with classical studies in 100 feature selection runs.

Dataset	Average balanced accuracy				Proposed BEV	Average number of selected features				Proposed BEV
	LFS	CFS	FCBF	ERM-FS		LFS	CFS	FCBF	ERM-FS
Lung cancer	79.62	93.76	92.71	93.25 $\pm$ 0.01	100 $\pm$ 0.00	8.5	517.0	439.4	61.00	12.1
11 Tumor	61.76	80.04	80.57	80.26$\pm$ 0.02	87.00 $\pm$ 3.49	17.3	361.6	349.6	292.60	430.6
Leukemia 2	89.44	94.44	95.56	98.12$\pm$ 0.01	100 ± 0.00	4.7	129.5	77.5	15.30	5.6
Prostate	90.17	92.17	92.17	96.12 ± 0.01	100 ± 0.00	5.9	80.4	66.1	11.00	6.4
Brain tumor 2	77.50	77.50	77.50	89.23 ± 0.03	98.00 ± 5.37	9.1	101.1	66.2	26.80	6.5
Brain tumor 1	63.33	76.6.7	73.75	83.26 ± 0.04	89.00 ± 0.00	12.2	151.9	104.6	32.44	7.3
9 tumor	26.67	56.67	55.00	64.44 ± 0.07	64.80 ± 7.04	9.7	44.0	33.7	89.40	108
DLBCL	83.33	93.00	94.83	98.09 ± 0.02	100 ± 0.00	5.9	86.3	66.1	14.20	6.0
Leukemia 1	85.14	92.08	89.86	97.93 ± 0.01	100 ± 0.00	5.4	79.4	48.5	22.80	6.1
SRBCT	91.67	99.17	98.75	100 ± 0.00	100 ± 0.00	7.1	112.3	69.0	31.00	10.4

Significant values are in bold.